Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 3/10

vs
industry
vs
history
Cash to Debt 0.55
HEWA's Cash to Debt is ranked lower than
66% of the 559 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.48 vs. HEWA: 0.55 )
HEWA' s 10-Year Cash to Debt Range
Min: 0   Max: No Debt
Current: 0.55

Equity to Asset -1.66
HEWA's Equity to Asset is ranked lower than
66% of the 559 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.42 vs. HEWA: -1.66 )
HEWA' s 10-Year Equity to Asset Range
Min: -4.37   Max: 0.84
Current: -1.66

-4.37
0.84
F-Score: 4
Z-Score: -18.98
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) -13.51
HEWA's Operating margin (%) is ranked lower than
65% of the 562 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.38 vs. HEWA: -13.51 )
HEWA' s 10-Year Operating margin (%) Range
Min: -145.68   Max: 8.45
Current: -13.51

-145.68
8.45
Net-margin (%) -17.86
HEWA's Net-margin (%) is ranked lower than
65% of the 562 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.19 vs. HEWA: -17.86 )
HEWA' s 10-Year Net-margin (%) Range
Min: -142.82   Max: 6.86
Current: -17.86

-142.82
6.86
ROA (%) -90.72
HEWA's ROA (%) is ranked lower than
65% of the 564 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 4.10 vs. HEWA: -90.72 )
HEWA' s 10-Year ROA (%) Range
Min: -307.05   Max: 12.84
Current: -90.72

-307.05
12.84
ROC (Joel Greenblatt) (%) -164.47
HEWA's ROC (Joel Greenblatt) (%) is ranked lower than
65% of the 563 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 18.27 vs. HEWA: -164.47 )
HEWA' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -1009.09   Max: 14.29
Current: -164.47

-1009.09
14.29
Revenue Growth (3Y)(%) -8.30
HEWA's Revenue Growth (3Y)(%) is ranked lower than
74% of the 496 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.70 vs. HEWA: -8.30 )
HEWA' s 10-Year Revenue Growth (3Y)(%) Range
Min: -62.1   Max: 84.2
Current: -8.3

-62.1
84.2
EBITDA Growth (3Y)(%) -7.70
HEWA's EBITDA Growth (3Y)(%) is ranked lower than
79% of the 465 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 6.00 vs. HEWA: -7.70 )
HEWA' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -79.5   Max: 98.8
Current: -7.7

-79.5
98.8
EPS Growth (3Y)(%) -16.90
HEWA's EPS Growth (3Y)(%) is ranked lower than
86% of the 427 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 7.30 vs. HEWA: -16.90 )
HEWA' s 10-Year EPS Growth (3Y)(%) Range
Min: -77.9   Max: 86.1
Current: -16.9

-77.9
86.1
» HEWA's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with HEWA

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/S 0.26
HEWA's P/S is ranked lower than
62% of the 589 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.55 vs. HEWA: 0.26 )
HEWA' s 10-Year P/S Range
Min: 0.27   Max: 29.23
Current: 0.26

0.27
29.23
Current Ratio 0.27
HEWA's Current Ratio is ranked lower than
65% of the 562 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.14 vs. HEWA: 0.27 )
HEWA' s 10-Year Current Ratio Range
Min: 0.06   Max: 5.83
Current: 0.27

0.06
5.83
Quick Ratio 0.24
HEWA's Quick Ratio is ranked lower than
65% of the 562 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.63 vs. HEWA: 0.24 )
HEWA' s 10-Year Quick Ratio Range
Min: 0.02   Max: 5.83
Current: 0.24

0.02
5.83

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.18
HEWA's Price/Median PS Value is ranked lower than
62% of the 589 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.10 vs. HEWA: 0.18 )
HEWA' s 10-Year Price/Median PS Value Range
Min: 0.21   Max: 12.5
Current: 0.18

0.21
12.5
Earnings Yield (Greenblatt) -32.70
HEWA's Earnings Yield (Greenblatt) is ranked lower than
66% of the 560 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.90 vs. HEWA: -32.70 )
HEWA' s 10-Year Earnings Yield (Greenblatt) Range
Min: 107.6   Max: 818
Current: -32.7

107.6
818

Business Description

Industry: Retail - Defensive » Pharmaceutical Retailers
Compare:SHDMF, APNHF, GNC, JCOUF, PMC » details
HealthWarehouse.com Inc was incorporated in the State of Delaware on August 5, 1998. The Company is a U.S. licensed virtual retail pharmacy and healthcare e-commerce company that sells brand name and generic prescription drugs as well as over-the-counter medical products. The Company is presently licensed as a mail-order pharmacy for sales to 50 states in the United States and the District of Columbia. Currently, it sells prescription drugs both brand name and generic; diabetic supplies including glucometers, lancets, syringes and test strips; OTC medications covering allergy and sinus to pain and fever to smoking cessation aids; diet and nutritional products including supplements, weight loss aids, and vitamins and minerals and pet medications. It also provides 90-day return policy with no restocking fees, and 100% free standard shipping on all orders. It sells directly to individual consumers who purchase prescription medications and OTC products. The Company's online pharmacy offers the following advantages: Legitimacy, Convenience, Selection, Information, Privacy, Value, and Customer Service. The Company's marketing strategy aims to build brand recognition, increase customer traffic to its online store, add new customers, build strong customer loyalty, maximize repeat purchases and develop incremental revenue opportunities. The Company's business is centered on Internet-based advertising. The Company filed for a trademark on the name HealthWarehouse.com on August 14, 2007 with the U.S. Patent and Trademark Office, which trademark was granted with a registration date of May 19, 2009. The Company's competitors in the segment include chain drugstores, mail order pharmacies, mass market retailers, warehouse clubs and supermarkets. Federal and state laws and regulations govern many aspects of its business and are specific to pharmacies and the sale of OTC drugs.

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK